Planned Solutions Inc. Buys Shares of 722 Houlihan Lokey, Inc. (NYSE:HLI)

Planned Solutions Inc. bought a new stake in Houlihan Lokey, Inc. (NYSE:HLI) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 722 shares of the financial services provider’s stock, valued at approximately $87,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Janiczek Wealth Management LLC acquired a new position in Houlihan Lokey during the third quarter valued at approximately $30,000. Anchor Investment Management LLC acquired a new position in shares of Houlihan Lokey during the 4th quarter worth $54,000. Pinebridge Investments L.P. bought a new stake in shares of Houlihan Lokey during the 2nd quarter worth $52,000. Harel Insurance Investments & Financial Services Ltd. boosted its stake in Houlihan Lokey by 100.0% in the third quarter. Harel Insurance Investments & Financial Services Ltd. now owns 600 shares of the financial services provider’s stock valued at $65,000 after buying an additional 300 shares in the last quarter. Finally, Bessemer Group Inc. grew its position in Houlihan Lokey by 225.5% in the second quarter. Bessemer Group Inc. now owns 638 shares of the financial services provider’s stock valued at $63,000 after acquiring an additional 442 shares during the last quarter. Institutional investors own 78.07% of the company’s stock.

Houlihan Lokey Trading Up 2.5 %

NYSE:HLI opened at $127.83 on Thursday. The stock’s 50-day moving average is $125.52 and its 200-day moving average is $115.08. The stock has a market cap of $8.83 billion, a P/E ratio of 31.72 and a beta of 0.68. Houlihan Lokey, Inc. has a 1-year low of $83.92 and a 1-year high of $133.80.

Houlihan Lokey (NYSE:HLI) last announced its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.12 by $0.10. The firm had revenue of $511.30 million during the quarter, compared to analysts’ expectations of $493.02 million. Houlihan Lokey had a net margin of 14.90% and a return on equity of 18.06%. The company’s revenue was up 12.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 EPS. As a group, equities analysts forecast that Houlihan Lokey, Inc. will post 4.36 EPS for the current year.

Houlihan Lokey Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a dividend of $0.55 per share. This represents a $2.20 annualized dividend and a yield of 1.72%. The ex-dividend date of this dividend was Thursday, February 29th. Houlihan Lokey’s payout ratio is presently 54.59%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on HLI shares. Keefe, Bruyette & Woods restated a “market perform” rating and issued a $127.00 price target on shares of Houlihan Lokey in a research note on Monday, January 29th. UBS Group raised their target price on shares of Houlihan Lokey from $136.00 to $142.00 and gave the company a “buy” rating in a research report on Friday, February 2nd.

Insider Buying and Selling at Houlihan Lokey

In other news, General Counsel Christopher M. Crain sold 1,000 shares of the firm’s stock in a transaction dated Friday, March 1st. The stock was sold at an average price of $128.94, for a total transaction of $128,940.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 25.97% of the company’s stock.

About Houlihan Lokey

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.